These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 30265714

  • 41. Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012.
    Juma DW, Omondi AA, Ingasia L, Opot B, Cheruiyot A, Yeda R, Okudo C, Cheruiyot J, Muiruri P, Ngalah B, Chebon LJ, Eyase F, Johnson J, Bulimo WD, Akala HM, Andagalu B, Kamau E.
    Malar J; 2014 Jul 02; 13():250. PubMed ID: 24989984
    [Abstract] [Full Text] [Related]

  • 42. Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.
    Sharma D, Lather M, Dykes CL, Dang AS, Adak T, Singh OP.
    Parasitol Res; 2016 Jan 02; 115(1):323-8. PubMed ID: 26407876
    [Abstract] [Full Text] [Related]

  • 43. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
    Fernandes N, Figueiredo P, do Rosário VE, Cravo P.
    Malar J; 2007 Mar 23; 6():35. PubMed ID: 17378942
    [Abstract] [Full Text] [Related]

  • 44. A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria.
    Adegbola AJ, Ijarotimi OA, Ubom AE, Adesoji BA, Babalola OE, Hocke EF, Hansson H, Mousa A, Bolaji OO, Alifrangis M, Roper C.
    Malar J; 2023 Mar 01; 22(1):71. PubMed ID: 36859238
    [Abstract] [Full Text] [Related]

  • 45. Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia.
    Basuki S, Fitriah, Risamasu PM, Kasmijati, Ariami P, Riyanto S, Hidayat A, Susilowati D, Iskandar, Armika B, Budiono, Dachlan YP, Kanbara H, Uemura H.
    Malar J; 2018 Dec 17; 17(1):475. PubMed ID: 30558597
    [Abstract] [Full Text] [Related]

  • 46. Sub-microscopic Plasmodium falciparum infections and multiple drug resistant single nucleotide polymorphic alleles in pregnant women from southwestern Nigeria.
    Ibekpobaoku AN, Oboh MA, Faal F, Adeniji E, Ajibaye O, Idowu ET, Amambua-Ngwa A.
    BMC Res Notes; 2024 May 09; 17(1):129. PubMed ID: 38725016
    [Abstract] [Full Text] [Related]

  • 47. Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy.
    Gresty KJ, Gray KA, Bobogare A, Wini L, Taleo G, Hii J, Cheng Q, Waters NC.
    Malar J; 2014 Oct 14; 13():402. PubMed ID: 25311473
    [Abstract] [Full Text] [Related]

  • 48. Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.
    Fortes F, Dimbu R, Figueiredo P, Neto Z, do Rosário VE, Lopes D.
    Malar J; 2011 Feb 02; 10():22. PubMed ID: 21288345
    [Abstract] [Full Text] [Related]

  • 49. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V, Das MK, Mittra P, Ahmed A, Kumar M, Kaur P, Dash AP, Singh SS, Sharma YD.
    J Infect Dis; 2009 Apr 01; 199(7):1064-73. PubMed ID: 19220141
    [Abstract] [Full Text] [Related]

  • 50. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana.
    Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA.
    Am J Trop Med Hyg; 2012 Dec 01; 87(6):996-1003. PubMed ID: 23045251
    [Abstract] [Full Text] [Related]

  • 51. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
    Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden Eng J, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP.
    Malar J; 2012 Jul 04; 11():134. PubMed ID: 22540158
    [Abstract] [Full Text] [Related]

  • 52. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
    Warsame M, Hassan AM, Barrette A, Jibril AM, Elmi HH, Arale AM, Mohammady HE, Nada RA, Amran JG, Muse A, Yusuf FE, Omar AS.
    Trop Med Int Health; 2015 Apr 04; 20(4):510-7. PubMed ID: 25583123
    [Abstract] [Full Text] [Related]

  • 53. Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation.
    Cohen O, Guemas E, Menard S, Tsague Kenfack M, Talom Ngassa C, Iriart X, Bidzogo Lebobo M, Ondobo Ekae C, Eboumbou C, Tiyou Kenmeni C, Berry A.
    J Antimicrob Chemother; 2023 Mar 02; 78(3):665-668. PubMed ID: 36611259
    [Abstract] [Full Text] [Related]

  • 54. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME, Mockenhaupt FP, Bienzle U, Elbashir MI, Giha HA.
    Infect Genet Evol; 2007 Jan 02; 7(1):52-9. PubMed ID: 16690361
    [Abstract] [Full Text] [Related]

  • 55. Characterization of putative drug resistant biomarkers in Plasmodium falciparum isolated from Ghanaian blood donors.
    Aninagyei E, Duedu KO, Rufai T, Tetteh CD, Chandi MG, Ampomah P, Acheampong DO.
    BMC Infect Dis; 2020 Jul 22; 20(1):533. PubMed ID: 32698879
    [Abstract] [Full Text] [Related]

  • 56. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F, Bakoua D, Fesser A, Nkombo M, Vouvoungui C, Ntoumi F.
    Infect Genet Evol; 2015 Jul 22; 33():32-6. PubMed ID: 25934142
    [Abstract] [Full Text] [Related]

  • 57. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
    Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T.
    Acta Trop; 2003 Mar 22; 85(3):363-73. PubMed ID: 12659974
    [Abstract] [Full Text] [Related]

  • 58. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA, Venkatesan M, Jacob CG, Artimovich EM, Nadeem MF, Nighat F, Hombhanje F, Mita T, Malik SA, Plowe CV.
    Malar J; 2013 Aug 29; 12():300. PubMed ID: 23988011
    [Abstract] [Full Text] [Related]

  • 59. Molecular Evidence for Plasmodium falciparum Resistance to Sulfadoxine-Pyrimethamine but Absence of K13 Mutations in Mangaluru, Southwestern India.
    Wedam J, Tacoli C, Gai PP, Siegert K, Kulkarni SS, Rasalkar R, Boloor A, Jain A, Mahabala C, Baliga S, Shenoy D, Devi R, Gai P, Mockenhaupt FP.
    Am J Trop Med Hyg; 2018 Dec 29; 99(6):1508-1510. PubMed ID: 30398146
    [Abstract] [Full Text] [Related]

  • 60. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B.
    Acta Trop; 2013 Dec 29; 128(3):636-41. PubMed ID: 24055717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.